Givatayim, Israel

Eva Schonberger


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1979-1980

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Eva Schonberger: A Trailblazer in Anti-Cancer Research**

Introduction

Eva Schonberger, a remarkable inventor based in Givatayim, IL, has made significant contributions to the field of medicinal chemistry. With a portfolio of two patented inventions, her work primarily focuses on enhancing the preparation processes of important anti-cancer compounds.

Latest Patents

Eva's latest patents include the groundbreaking invention of Bis-2-furanidyl ether and its novel method of preparation. This process involves the production of N.sup.1 -(2'-furanidyl)-5-fluoro-uracil, commonly known as Ftorafur, an essential anti-cancer compound. The method outlines a chemical reaction where 2,3-dihydrofuran reacts with water, utilizing a catalytic amount of an acidic catalyst under controlled pH conditions. By removing excess unreacted materials and further reacting with silylated-5-fluoro-uracil in the presence of a Friedel Crafts type catalyst, the new process offers numerous advantages compared to prior methodologies, improving efficiency and effectiveness in drug formulation.

Career Highlights

Eva's career has been marked by her association with Abic Ltd., where she has played a crucial role in advancing cancer treatment research. Her commitment to innovation is evidenced by her dedication to developing new processes that could potentially revolutionize the production of life-saving medications.

Collaborations

Throughout her career, Eva has collaborated with notable colleagues such as Zabar Sasson and Uri Michael. These partnerships have fostered a creative environment conducive to groundbreaking research and the development of effective therapeutic solutions.

Conclusion

Eva Schonberger's contributions to the field of anti-cancer research are invaluable. Her innovative approaches and effective methodologies demonstrate her commitment to improving patient outcomes. As she continues her work at Abic Ltd., the medical community eagerly anticipates the advancements her inventions will bring to cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…